Latest News

In early February 2026, ZTO Express (Cayman) Inc. issued 2025 guidance calling for higher revenues but lower gross profit versus 2024, and completed a US$1.50 billion callable, convertible senior unsecured bond offering due 2031 priced at par with a 0.925% fixed coupon. The combination of rising parcel volumes, thinner margins, and using low-coupon convertible debt to fund refinancing, capped calls, and share repurchases adds a complex layer to how investors may assess ZTO’s capital...

Gentex Corporation recently reported fourth-quarter 2025 results, with sales rising to US$644.4 million and net income increasing to US$92.96 million, alongside higher earnings per share than a year earlier. The company also issued multi-year revenue guidance through 2027 and completed a US$99.08 million share repurchase, underscoring management’s confidence in its operating outlook and capital allocation approach. We’ll now examine how Gentex’s upbeat multi-year revenue guidance shapes its...

Banca Popolare di Sondrio (BIT:BPSO) just released its full year 2025 results, reporting net income of €648 million versus €574.9 million a year earlier, a shift that helps explain recent share performance. See our latest analysis for Banca Popolare di Sondrio. The higher 2025 net income comes alongside firm share price momentum, with a 17.77% 90 day share price return and a 1 year total shareholder return of 108.02% pointing to stronger sentiment building around the stock. If you are looking...

Aozora Bank, Ltd. reported earnings for the nine months ended December 31, 2025, showing higher net interest income of ¥37,272 million and net income of ¥21,825 million, alongside increased basic earnings per share of ¥157.72 from continuing operations. On the same day, the bank also affirmed a quarterly dividend of ¥22.00 per share payable on June 25, 2026, underscoring its focus on returning cash to shareholders while earnings per share continued to rise. We will now examine how Aozora...

Tokyo Electric Power Company Holdings reported past nine‑month results to December 2025 showing revenue of ¥4,612,176 million and a net loss of ¥662.65 billion, alongside government approval of a new turnaround plan featuring ¥3.10 trillion of cost cuts and about ¥200 billion of asset sales over the coming decade. An interesting twist is that this deep restructuring push, including potential external capital partnerships to fund data‑center‑related investment, comes alongside plans for a...

Context for Nippon Express Holdings after recent performance Nippon Express Holdings (TSE:9147) has drawn attention after a 1-day return of 1.6%, with gains over the past week, month, and past 3 months, prompting a closer look at its recent fundamentals. See our latest analysis for Nippon Express Holdings. At a share price of ¥3,733.0, Nippon Express Holdings has recently shown steady momentum, with a 30 day share price return of 8.1% and a 1 year total shareholder return of 55.4%. This...

Yum China Holdings reported past fourth-quarter 2025 results showing higher sales of US$2,627 million and revenue of US$2,823 million, with net income rising to US$140 million, alongside a 21% dividend increase and continued share repurchases. The company also added 1,706 net new stores in 2025, bringing its network to 18,101 locations and highlighting rapid nationwide scale-up in China’s restaurant market. Against this backdrop, we’ll explore how Yum China’s accelerated store expansion...

Earlier this week, ZoomInfo Technologies (NASDAQ: GTM) reported earnings after previously outperforming revenue expectations and guiding earnings per share ahead of analyst forecasts, while the board granted CEO Henry Schuck a one-time, performance-based option award on 9.7 million shares tied to ambitious targets. This unusually large, performance-linked grant has drawn attention to potential changes in ZoomInfo’s business direction, including sharper execution priorities or the possibility...

Energizer Holdings, Inc. recently reaffirmed its second-quarter and full-year 2026 guidance, expecting a 4% to 5% organic net sales decline in the quarter but flat to slightly higher organic net sales across its Batteries and Lights and Auto Care segments for the full year, while its Board declared a US$0.30 per-share dividend payable in March 2026. Despite margin pressures from tariffs and operational inefficiencies, Energizer exceeded adjusted earnings expectations, generated strong cash...

Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...

Shareholders might have noticed that Afry AB ( STO:AFRY ) filed its yearly result this time last week. The early...

The annual results for Eastnine AB (publ) ( STO:EAST ) were released last week, making it a good time to revisit its...

The Middle Eastern stock markets have recently shown positive momentum, driven by encouraging developments in US-Iran diplomatic talks and record highs in Egypt's indices. Amidst this backdrop, the concept of penny stocks continues to hold relevance as these smaller or newer companies can present unique investment opportunities when they possess strong financial foundations. In this article, we will explore three noteworthy penny stocks from the region that stand out for their financial...

As the Middle East markets experience a positive shift, buoyed by upbeat US-Iran talks and record highs in Egypt's indices, investors are increasingly optimistic about the region's economic prospects. In this environment, identifying stocks with strong fundamentals and growth potential becomes crucial for those looking to capitalize on emerging opportunities.

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

GP ECO Solutions India (NSE:GPECO) has had a rough three months with its share price down 24%. But if you pay close...

Market context and recent performance Corvus Pharmaceuticals (CRVS) has drawn investor attention after a sharp share price move, with the stock up 7.35% in the latest session and posting significant gains over the past month. See our latest analysis for Corvus Pharmaceuticals. The latest move sits within a very strong run, with a 30 day share price return of 201.33% and year to date share price return of 179.51%. The 1 year total shareholder return of 306.76% and very large 3 year total...

UGI (UGI) is back in focus after reporting first quarter results that included a 5% year over year EBIT increase, the completion of its LPG portfolio rationalization, and a Moody’s outlook upgrade for AmeriGas. See our latest analysis for UGI. Despite the recent EBIT progress and LPG portfolio clean up, UGI’s share price has been under some pressure in the short term, with a 1 day share price return of a 2% decline and a 7 day share price return of a 7.6% decline, while the 90 day share price...

Why lucerastat’s new Phase 3 plan matters for Idorsia shareholders Idorsia (SWX:IDIA) has agreed with the US FDA on a Phase 3 registration program for lucerastat in Fabry disease, centered on kidney outcomes and backed by recently published MODIFY trial data. For you as an investor, this means lucerastat is moving from exploratory late stage data into a clearly defined path that is intended to support a potential marketing application, with health authority alignment already in place. See our...

Neogen Corporation recently initiated a voluntary recall of all in-date lots of its Vet HYCOAT Hyaluronate Sodium Sterile Solution for animals, after microbial contamination was detected in certain 10 mL/50 mg vials and adverse events were reported in horses when used off-label as intraarticular injections. Although no adverse events have been reported when HYCOAT is used as labeled for topical wound management, the company has extended the recall to additional lot sizes and is working with...

Konecranes (HLSE:KCR) has just combined a proposed €2.25 per share dividend, fresh 2026 guidance and solid 2025 results, giving investors new information on cash returns, earnings power and order momentum in eco efficient equipment. See our latest analysis for Konecranes. The recent dividend proposal and steady 2026 guidance come after a mixed stretch in the share price, with a 7 day share price return of a 10.44% decline but a 90 day share price return of 8.04%, while the 1 year total...

Why Aurubis stock is back on investors’ radar Aurubis (XTRA:NDA) has drawn fresh attention after raising its 2025–26 operating EBT guidance to €375 million to €475 million. This follows a first quarter with higher sales and net income versus a year earlier. See our latest analysis for Aurubis. The raised guidance and strong first quarter have coincided with a sharp move in the stock, with a 30.35% year to date share price return and a 102.07% total shareholder return over the past year...

Essity’s New EIB Loan and Why It Matters for Shareholders Essity (OM:ESSITY B) has secured a €400 million, 7 year loan from the European Investment Bank. The funds are earmarked for research, development, and innovation across all business areas, with a focus on competitiveness and environmental impact. See our latest analysis for Essity. The new EIB loan arrives after a period of steady gains, with Essity’s share price at SEK278.8 and recent upward momentum reflected in its 7 day and 30 day...

Nurix Therapeutics (NRIX) is in focus after reporting full year 2025 earnings that paired revenue of US$83.98 million with a wider net loss of US$264.46 million, alongside a new US$98.8 million shelf registration. See our latest analysis for Nurix Therapeutics. The latest earnings release and shelf registration have arrived after a volatile stretch, with a 31.03% 90 day share price return contrasting with a 12.69% 30 day decline and a 6.44% 1 year total shareholder return fall. This suggests...